跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
radiosensitizer
首页
药物
radiosensitizer
radiosensitizer
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FUNCTIONALLY MODIFIED MAYTANSINOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF
EP 4072540 A4
申请人: UNIV GEORGIA
优先权: 2019
CN
EP
US
WO
7 件公开
Radiation sensitizer or anti-cancer chemotherapy sensitizer
US 10219997 B2
申请人: OGAWA YASUHIRO
优先权: 2006
CN
EP
US
6 件公开
USE OF PCLX-001 OR PCLX-002 AS A RADIOSENSITIZER
EP 4648775 A1
申请人: PACYLEX PHARMACEUTICALS INC
优先权: 2023
CN
EP
US
WO
4 件公开
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER USING AN INHIBITOR OF PRM T5
EP 4770673 A1
申请人: PURDUE RESEARCH FOUNDATION
优先权: 2023
CN
EP
WO
3 件公开
Radiosensitizer
US 2007219145 A1
申请人: SAKIMOTO IPPEI
优先权: 2004
CN
US
3 件公开
US 2006217291 A1
申请人: HIROTSU ICHIRO
优先权: 2005
EP
US
2 件公开
CN 113507939 A
申请人: M T 3 INC
优先权: 2019
CN
Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
US 7018371 B2
申请人: XOFT INC
优先权: 2001
US
3 件公开
Radiosensitizer formulations and methods for use
US 7608612 B2
申请人: MATTHEWS RICHARD H
优先权: 2006
US
3 件公开
Use of photofrin as a radiosensitizer
US 2001051760 A1
申请人: HOFSTETTER ALFONS
优先权: 2000
EP
US
2 件公开
COMPOSITIONS FOR RELEASE OF RADIOSENSITIZERS, AND METHODS OF MAKING AND USING THE SAME
WO 0230472 A3
申请人: GUILFORD PHARM INC
优先权: 2000
US
WO
2 件公开
RADIOPROTECTION BY INHIBITION OF SUPEROXIDE DISMUTASE 1
EP 4687863 A1
申请人: DEUTSCHES KREBSFORSCH
优先权: 2023
EP
WO
2 件公开
第 1 / 6 页
上一页
下一页
药物
反馈